Mereo BioPharma (NASDAQ: MREO) given 2027 Nasdaq deadline
Mereo BioPharma Group plc (MREO) has received a second notice from Nasdaq regarding its failure to meet the minimum $1.00 bid price requirement. The company has been granted an additional 180-day compliance period, until February 16, 2027, to regain compliance by achieving a closing …